{"id":54799,"date":"2023-03-14T11:06:31","date_gmt":"2023-03-14T10:06:31","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/"},"modified":"2023-03-14T11:06:31","modified_gmt":"2023-03-14T10:06:31","slug":"stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","title":{"rendered":"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences &amp; MedTech Investor Forum"},"content":{"rendered":"<div>\n<p>PIOMBINO DESE, Italy&#8211;(BUSINESS WIRE)&#8211;Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Virtual KeyBanc Capital Markets Life Sciences &amp; MedTech Investor Forum taking place on March 21 and March 22, 2023.\n<\/p>\n<p>\nThe Company will present on Tuesday, March 21, 2023 at 11:15 a.m. ET. A live audio webcast will be available on the Company\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.stevanatogroup.com&amp;esheet=53361527&amp;newsitemid=20230314005400&amp;lan=en-US&amp;anchor=www.stevanatogroup.com&amp;index=1&amp;md5=2dbedfad22f8c86ce54a2986dea38d8e\" rel=\"nofollow noopener\" shape=\"rect\">www.stevanatogroup.com<\/a> under the &#8220;Investors&#8221; section of the website. A replay will be available for approximately 90 days after the event.\n<\/p>\n<p>\n<b>About Stevanato Group<\/b>\n<\/p>\n<p>\nFounded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group\u2019s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.\n<\/p>\n<p>\nFor more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.stevanatogroup.com%2F&amp;esheet=53361527&amp;newsitemid=20230314005400&amp;lan=en-US&amp;anchor=www.stevanatogroup.com&amp;index=2&amp;md5=b274991391433d8fd856e35a9428c182\" rel=\"nofollow noopener\" shape=\"rect\">www.stevanatogroup.com<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media<\/b><br \/>Stevanato Group<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;&#108;t&#x6f;&#x3a;&#x6d;&#101;&#100;i&#x61;&#x40;&#x73;&#116;&#101;v&#x61;&#x6e;&#x61;&#116;&#111;g&#x72;&#x6f;&#x75;&#112;&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6d;&#x65;&#x64;&#x69;&#x61;&#x40;&#x73;&#x74;&#101;&#118;&#97;&#110;&#97;&#116;&#111;grou&#x70;&#x2e;&#x63;&#x6f;&#x6d;<\/a>\n<\/p>\n<p>\n<b>Investor Relations<\/b><br \/>Lisa Miles<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;&#x74;&#111;:&#x6c;&#105;&#x73;&#97;&#46;&#x6d;&#105;&#x6c;&#101;s&#x40;s&#x74;&#101;&#x76;&#x61;n&#x61;&#116;&#x6f;&#103;r&#x6f;&#117;&#x70;&#46;c&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x6c;&#x69;&#x73;&#x61;&#x2e;&#x6d;&#x69;&#x6c;&#x65;&#x73;&#x40;&#x73;&#x74;&#x65;&#x76;&#x61;&#x6e;&#x61;&#x74;&#x6f;&#x67;&#x72;&#x6f;&#x75;&#x70;&#x2e;&#x63;&#x6f;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>PIOMBINO DESE, Italy&#8211;(BUSINESS WIRE)&#8211;Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Virtual KeyBanc Capital Markets Life Sciences &amp; MedTech Investor Forum taking place on March 21 and March 22, 2023. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54799","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Stevanato Group to Present at KeyBanc Capital Markets Life Sciences &amp; MedTech Investor Forum - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences &amp; MedTech Investor Forum - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PIOMBINO DESE, Italy&#8211;(BUSINESS WIRE)&#8211;Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Virtual KeyBanc Capital Markets Life Sciences &amp; MedTech Investor Forum taking place on March 21 and March 22, 2023. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-14T10:06:31+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences &amp; MedTech Investor Forum\",\"datePublished\":\"2023-03-14T10:06:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\"},\"wordCount\":228,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\",\"name\":\"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences &amp; MedTech Investor Forum - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2023-03-14T10:06:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences &amp; MedTech Investor Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences &amp; MedTech Investor Forum - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","og_locale":"en_US","og_type":"article","og_title":"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences &amp; MedTech Investor Forum - Pharma Trend","og_description":"PIOMBINO DESE, Italy&#8211;(BUSINESS WIRE)&#8211;Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Virtual KeyBanc Capital Markets Life Sciences &amp; MedTech Investor Forum taking place on March 21 and March 22, 2023. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-14T10:06:31+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences &amp; MedTech Investor Forum","datePublished":"2023-03-14T10:06:31+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/"},"wordCount":228,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","url":"https:\/\/pharma-trend.com\/en\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","name":"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences &amp; MedTech Investor Forum - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2023-03-14T10:06:31+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences &amp; MedTech Investor Forum"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54799"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54799\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}